![Yvonne McGrath](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yvonne McGrath
Hoofd Techniek/Wetenschap/O&O bij
ITEOS THERAPEUTICS, INC.
Profiel
Yvonne McGrath currently works at iTeos Therapeutics, Inc., as Chief Scientific Officer from 2022.
Dr. McGrath also formerly worked at Complix NV, as Director & Chief Scientific Officer from 2014 to 2020, Immunocore Holdings Plc, as Head-Development from 2010 to 2014, and Immunocore Ltd., as Head-Development from 2010 to 2014.
Dr. McGrath received her undergraduate degree from Queen’S University Belfast and doctorate degree from Cardiff University School of Medicine.
Actieve functies van Yvonne McGrath
| Bedrijven | Functie | Begin |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2020 |
Eerdere bekende functies van Yvonne McGrath
| Bedrijven | Functie | Einde |
|---|---|---|
Complix NV
 Complix NV Pharmaceuticals: MajorHealth Technology Engages in the development of biopharmaceutical | Hoofd Techniek/Wetenschap/O&O | 01-04-2020 |
| IMMUNOCORE HOLDINGS PLC | Corporate Officer/Principal | 01-04-2014 |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Corporate Officer/Principal | 01-04-2014 |
Opleiding van Yvonne McGrath
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
30
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Complix NV
Complix NV Pharmaceuticals: MajorHealth Technology Engages in the development of biopharmaceutical | Health Technology |
Cardiff University School of Medicine
 Cardiff University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iTeos Therapeutics, Inc.
 iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Queen’S University Belfast
 Queen’S University Belfast Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Health Technology |
